These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29372079)

  • 21. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
    Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
    Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
    Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
    Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
    Chang WM; Lin YF; Su CY; Peng HY; Chang YC; Lai TC; Wu GH; Hsu YM; Chi LH; Hsiao JR; Chen CL; Chang JY; Shieh YS; Hsiao M; Shiah SG
    Cancer Res; 2016 Dec; 76(24):7140-7150. PubMed ID: 27760788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Toxic Masculinity': What Is Known about the Role of Androgen Receptors in Head and Neck Squamous Cell Carcinoma.
    Čonkaš J; Sabol M; Ozretić P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis.
    Zhao YY; Yu GT; Xiao T; Hu J
    Adv Clin Exp Med; 2017 Aug; 26(5):881-887. PubMed ID: 29068587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
    Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
    Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
    Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
    Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Junctional Adhesion Molecule-A in Head and Neck Squamous Cell Carcinoma.
    Kurose M; Kakuki T; Takano K; Kondo A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Kojima T; Himi T
    Adv Otorhinolaryngol; 2016; 77():92-7. PubMed ID: 27115511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer.
    Sharpe DJ; Orr KS; Moran M; White SJ; McQuaid S; Lappin TR; Thompson A; James JA
    Oncotarget; 2014 Sep; 5(18):8803-15. PubMed ID: 25301728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.
    Gasparotto D; Polesel J; Marzotto A; Colladel R; Piccinin S; Modena P; Grizzo A; Sulfaro S; Serraino D; Barzan L; Doglioni C; Maestro R
    Oncotarget; 2011 Dec; 2(12):1165-75. PubMed ID: 22201613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
    Jin Y; Qin X
    DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
    Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
    Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma.
    Tang Y; Li C; Zhang YJ; Wu ZH
    Int J Biol Sci; 2021; 17(3):702-711. PubMed ID: 33767582
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.